Early coronary CTA for suspected ACS not cost effective

In this large multi center trial of patients with suspected ACS, but with non-ischemic EKG and normal troponins, they were randomized to usual evaluation or coronary CTA. The mean LOS in the hospital was reduced by 7.6 hours with CTA, but there was no difference in the overall cost of care, and there was higher radiation exposure and downstream testing in those randomized to CTA. Overall, early CTA testing for suspected ACS increased radiation exposure with no reduction in overall cost of care (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment